HODGKINS AND NON HODGKINS LYMPHOMA (2)

Annet Angwech

Lymphomas are malignancies of lymphoid cells that can present as solid tumors or leukemias. They are divided into Hodgkin lymphoma (≈15%) and non‑Hodgkin lymphoma (≈85%) based on the presence of Reed‑Sternberg cells. The document describes indolent, aggressive, and very aggressive behavior patterns, highlights key subtypes such as Burkitt, small lymphocytic, ALCL, and Sezary syndrome, and outlines diagnostic work‑up including imaging and biopsies. Treatment recommendations emphasize the role of rituximab‑based chemoimmunotherapy for indolent NHL and standard regimens for aggressive disease, while noting long‑term toxicities. Epidemiologic data from Uganda and global incidence trends are also presented.